Mar 6, 2026 06:15PM
Mar 6, 2026 06:15PM
Aug 21, 2025 06:41AM
Jun 17, 2025 08:00AM
May 8, 2025 04:05PM
Nov 19, 2024 08:30AM
Sep 5, 2024 08:00AM Lisata Therapeutics' (LSTA) Certepetide Granted FDA Orphan Drug Designation for the Treatment of Cholangiocarcinoma
Sep 5, 2024 08:00AM
Aug 12, 2024 04:05PM
May 9, 2024 04:05PM
Apr 9, 2024 08:30AM
Apr 9, 2024 08:30AM
Mar 21, 2024 08:03AM
Mar 21, 2024 08:00AM Lisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of Osteosarcoma
Feb 29, 2024 04:05PM
Jan 17, 2024 08:00AM
Nov 2, 2023 04:05PM
Aug 14, 2023 04:05PM
Aug 14, 2023 04:05PM
Aug 8, 2023 08:00AM
Aug 8, 2023 08:00AM Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Malignant Glioma
Nov 10, 2022 04:05PM
Nov 10, 2022 04:05PM
Sep 15, 2022 09:15AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All